A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides
Kailu Yang, Chuchu Wang, Francesco Topi, Serena Muratcioğlu, Ravi Kant, Tomas M. Strandin, Yih Tyng Bong, Lauri Kareinen, Sanna Mäki, Saber H. Saber, Tobias Binder, Tarja A. Sironen, Subu K. Subramanian, K. Ian White, Richard A. Pfuetzner, , Axel T. Brünger
This study designs and validates protease-resistant antiviral peptides that inhibit SARS-CoV-2 fusion, showing improved efficacy in vitro and in vivo.
bioRxiv · Nov 2, 2026 · PreprintMicrobiology